Cancer Survival Rate Up in Europe
"Cancer survival has improved across Europe, with eastern European nations beginning to close the gap with western neighbours, according to a study covering the decade up to 2002, released Tuesday.
The study, published in the British journal The Lancet, showed a clear link between high rates of survival and the amount spent on health, but pointed out that Britain lagged well behind other countries with similar national health budgets.
An accompanying editorial in the influential journal called for a "fundamental reassessment" of Britain's cancer policy in light of the fact that survival rates were comparable to eastern European countries that spent two-thirds less.
"So has the cancer plan worked? The short answer is seemingly no," it concluded, suggesting that the National Health Service should be "divorced from political control and short-term political gains."
Oh you mean the effort to place health care budgets under the wise and experienced direction of bureaucrats seeking to bring costs under control by limiting access to drugs in the political spotlight is killing patients? The most the NHS spends the less it gets for its dollars.
As in NICE which is hailed as the gold standard of comparative effectiveness and cost effectiveness evaluation by the folks at AHIP, Commonwealth Fund, HealthDespairs, Medpac and now at CMS.
Our government -- in the form of the FDA and now at CMS -- is at war against cancer patients. It is a direct result of the policies pursued by those whose politics are shaped by unchecked hatred against the companies that make medicines. They are supported by a fawning media, by nuts on the net, and financially by trial attorneys. They are killing patients and crippling their lives. Well done.